Ind. Code ch. 16-42-24

in effect

Ind. Code § 16-42-24-1 Record of use

Sec. 1. The state department shall establish a record keeping system concerning the use of chymopapain and its effectiveness. The state department may require neurosurgeons and orthopedic surgeons to supply information concerning the use of chymopapain. [Pre-1993 Recodification Citation: 16-8-10-1(a).] As added by P.L.2-1993, SEC.25.

Ind. Code § 16-42-24-2 Administration restricted

Sec. 2. Only a neurosurgeon or an orthopedic surgeon may administer chymopapain. Chymopapain may only be administered in a hospital licensed under IC 16-21-2. [Pre-1993 Recodification Citation: 16-8-10-1(b).] As added by P.L.2-1993, SEC.25.

Ind. Code § 16-42-24-3 Hospital's restricting or forbidding use prohibited; conditions

Sec. 3. Except as provided in section 10 of this chapter, a hospital may not interfere with the physician-patient relationship by restricting or forbidding the use of chymopapain for treatment of certain back ailments if the following conditions are met: (1) Chymopapain is administered by a neurosurgeon or an orthopedic surgeon holding an unlimited license to practice medicine in Indiana. (2) The patient has signed the request form described in section 7 of this chapter. [Pre-1993 Recodification Citation: 16-8-10-1(c).] As added by P.L.2-1993, SEC.25.

Ind. Code § 16-42-24-4 Disciplinary action against attending physician prohibited if use requested by patient

Sec. 4. A neurosurgeon or an orthopedic surgeon may not be subjected to disciplinary action by the medical licensing board of Indiana for administering chymopapain to a patient under the neurosurgeon's or orthopedic surgeon's care to treat certain back ailments if the patient has signed the request form described in section 7 of this chapter. [Pre-1993 Recodification Citation: 16-8-10-2.] As added by P.L.2-1993, SEC.25. Amended by P.L.1-2025, SEC.185.

Ind. Code § 16-42-24-5 Use permitted in place of other therapies if requested by patient

Sec. 5. A neurosurgeon or an orthopedic surgeon may administer chymopapain instead of other modes of therapy for treatment of certain back ailments of a patient who has signed the request form described in section 7 of this chapter. [Pre-1993 Recodification Citation: 16-8-10-3.] As added by P.L.2-1993, SEC.25.

Ind. Code § 16-42-24-6 Construction of chapter

Sec. 6. This chapter is not an endorsement of chymopapain for the treatment of back ailments. [Pre-1993 Recodification Citation: 16-8-10-4.] As added by P.L.2-1993, SEC.25.

Ind. Code § 16-42-24-7 Use request form

Sec. 7. (a) The state department shall prepare a form for a patient to use to request administration of chymopapain. The form must be substantially in the following form: REQUEST FOR ADMINISTRATION OF CHYMOPAPAIN FOR MEDICAL TREATMENT Patient's name _______________________________ Address _____________________________________ Age ___________ Sex ____________ Name and address of administering physician _____________________________________________ Physical condition diagnosed for medical treatment by chymopapain _____________________________________________ _____________________________________________ My physician has explained the following to me: (1) That the manufacture and distribution of chymopapain has been banned by the federal Food and Drug Administration. (2) That there are alternative recognized treatments for the back ailment from which I suffer that my physician has offered to provide for me, including the following: (Here describe) ____________________________________________ ____________________________________________ Notwithstanding this explanation, I request the administration of chymopapain in the medical treatment of the back ailment from which I suffer. _______________________________________ Patient or person signing for patient ATTEST: ______________________________________ Prescribing physician (b) A copy of the request form shall be sent immediately after execution to the state department. [Pre-1993 Recodification Citation: 16-8-10-5.] As added by P.L.2-1993, SEC.25.

Ind. Code § 16-42-24-8 Regulation of manufacture, distribution, sale, or use

Sec. 8. (a) Chymopapain is not a drug or a controlled substance under Indiana statutes governing the use, manufacture, or distribution of drugs and controlled substances within Indiana. (b) The state department and the Indiana board of pharmacy may regulate the manufacture, distribution, and sale of chymopapain for use within Indiana only to ensure that the substance is not adulterated or misbranded within the meaning of IC 16-42-3. (c) The state department may not adopt a rule that prohibits the use of chymopapain in a hospital or health care facility licensed by the state department. (d) The Indiana board of pharmacy may not adopt a rule that prohibits the manufacture, distribution, or sale of chymopapain by a person or in a place licensed by the Indiana board of pharmacy. [Pre-1993 Recodification Citation: 16-8-10-6.] As added by P.L.2-1993, SEC.25.

Ind. Code § 16-42-24-9 Manufacture, sale, distribution, or prescription not required

Sec. 9. (a) This chapter does not require a: (1) physician; (2) pharmacist; (3) pharmacy; (4) manufacturer; or (5) distributor; to manufacture, sell, or distribute chymopapain. (b) This chapter does not require a physician to prescribe chymopapain for a patient. [Pre-1993 Recodification Citation: 16-8-10-7(a).] As added by P.L.2-1993, SEC.25.

Ind. Code § 16-42-24-10 Use prohibition by health care facility facing loss of federal funding

Sec. 10. If: (1) the federal government indicates that the federal government will withdraw all federal funds from a health care facility for allowing chymopapain to be used within the facility; and (2) providing or allowing use of chymopapain within the facility would jeopardize the receipt of: (A) federal funds for reimbursement for Medicare or Medicaid for all persons within the facility; or (B) construction funds provided by the federal government under the Hill-Burton Hospital Construction Program (42 U.S.C. 291 et seq.) or under Title XVI of the Public Health Services Act (42 U.S.C. 300q-300t); the hospital or other health care facility may prohibit the use of chymopapain within the hospital or facility. [Pre-1993 Recodification Citation: 16-8-10-7(b).] As added by P.L.2-1993, SEC.25.

Source: Open US Law by Vaquill AI (CC BY 4.0)URL: https://iga.in.gov/laws/2026/ic/titles/16Fetched: 10/17/2026